(Q34365192)

1 August 2017

1 reference

title

Advances in directed protein evolution by recursive genetic recombination: applications to therapeutic proteins (English)

1 reference

1 August 2017

0 references

Kurtzman AL

1

1 reference

1 August 2017

Govindarajan S

2

1 reference

1 August 2017

Vahle K

3

1 reference

1 August 2017

Jones JT

4

1 reference

1 August 2017

Heinrichs V

5

1 reference

1 August 2017

Patten PA

6

1 reference

1 August 2017

publication date

1 August 2001

1 reference

Current Opinion in Biotechnology

1 August 2017

published in

1 reference

1 August 2017

volume

12

1 reference

1 August 2017

issue

4

1 reference

1 August 2017

page(s)

361-370

1 reference

Rapid evolution of a protein in vitro by DNA shuffling

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900228-7

7 January 2021

DNA shuffling by random fragmentation and reassembly: in vitro recombination for molecular evolution

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900228-7

7 January 2021

DNA shuffling of a family of genes from diverse species accelerates directed evolution

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900228-7

7 January 2021

When blind is better: protein design by evolution

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900228-7

7 January 2021

Evolution of a cytokine using DNA family shuffling

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900228-7

7 January 2021

Tuning the activity of an enzyme for unusual environments: sequential random mutagenesis of subtilisin E for catalysis in dimethylformamide

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900228-7

7 January 2021

Directed evolution of subtilisin E in Bacillus subtilis to enhance total activity in aqueous dimethylformamide

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900228-7

7 January 2021

THE RELATION OF RECOMBINATION TO MUTATIONAL ADVANCE

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900228-7

7 January 2021

Different structural requirements for plasminogen activator inhibitor 1 (PAI-1) during latency transition and proteinase inhibition as evidenced by phage-displayed hypermutated PAI-1 libraries

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900228-7

7 January 2021

Directed evolution of proteins by exon shuffling

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900228-7

7 January 2021

DNA shuffling method for generating highly recombined genes and evolved enzymes

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900228-7

7 January 2021

Molecular evolution by staggered extension process (StEP) in vitro recombination

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900228-7

7 January 2021

High efficiency family shuffling based on multi-step PCR and in vivo DNA recombination in yeast: statistical and functional analysis of a combinatorial library between human cytochrome P450 1A1 and 1A2

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900228-7

7 January 2021

Protein engineering by cDNA recombination in yeasts: shuffling of mammalian cytochrome P-450 functions

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900228-7

7 January 2021

Recombination between similar but not identical DNA sequences during yeast transformation occurs within short stretches of identity

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900228-7

7 January 2021

An effective family shuffling method using single-stranded DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900228-7

7 January 2021

Libraries of hybrid proteins from distantly related sequences

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900228-7

7 January 2021

Rapid generation of incremental truncation libraries for protein engineering using alpha-phosphothioate nucleotides.

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900228-7

7 January 2021

Finding Cinderella's slipper--proteins that fit

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900228-7

7 January 2021

Homology-independent protein engineering

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900228-7

7 January 2021

Improved green fluorescent protein by molecular evolution using DNA shuffling

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900228-7

7 January 2021

Tailoring in vitro evolution for protein affinity or stability

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900228-7

7 January 2021

Molecular breeding of carotenoid biosynthetic pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900228-7

7 January 2021

Directed molecular evolution of cytochrome c peroxidase

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900228-7

7 January 2021

Directed evolution of thymidine kinase for AZT phosphorylation using DNA family shuffling

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900228-7

7 January 2021

DNA shuffling of subgenomic sequences of subtilisin

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900228-7

7 January 2021

Directed evolution of ampicillin-resistant activity from a functionally unrelated DNA fragment: A laboratory model of molecular evolution

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900228-7

7 January 2021

The biologic activity and molecular characterization of a novel synthetic interferon-alpha species, consensus interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900228-7

7 January 2021

Side effects of alpha interferon in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900228-7

7 January 2021

Directed evolution of antibody fragments with monovalent femtomolar antigen-binding affinity

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900228-7

7 January 2021

Affinity dependence of the B cell response to antigen: a threshold, a ceiling, and the importance of off-rate

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900228-7

7 January 2021

Kinetic and affinity limits on antibodies produced during immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900228-7

7 January 2021

Picomolar affinity antibodies from a fully synthetic naive library selected and evolved by ribosome display

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900228-7

7 January 2021

Yeast surface display for screening combinatorial polypeptide libraries

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900228-7

7 January 2021

Antigen specificity and tumour targeting efficiency of a human carcinoembryonic antigen-specific scFv and affinity-matured derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900228-7

7 January 2021

Optimization of DNA shuffling for high fidelity recombination

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900228-7

7 January 2021

Brief report: complete deficiency of plasminogen-activator inhibitor type 1 due to a frame-shift mutation

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900228-7

7 January 2021

Molecular breeding of viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900228-7

7 January 2021

Breeding of retroviruses by DNA shuffling for improved stability and processing yields

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900228-7

7 January 2021

A RACHITT for our toolbox

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900228-7

7 January 2021

Site-specific mutagenesis of the human fibroblast interferon gene

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900228-7

7 January 2021

Clinical utility of external immunoscintigraphy with the IMMU-4 technetium-99m Fab' antibody fragment in patients undergoing surgery for carcinoma of the colon and rectum: results of a pivotal, phase III trial. The Immunomedics Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900228-7

7 January 2021

Molecular cloning and nucleotide sequence of human glucocerebrosidase cDNA

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900228-7

7 January 2021

Enzyme therapy for Gaucher disease: the first 5 years

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900228-7

7 January 2021

Production of soluble CD34 by human myeloid cells

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900228-7

7 January 2021

Synthesis and in vitro bioactivity of C-terminal deleted analogs of human growth hormone-releasing factor.

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900228-7

7 January 2021

Humanization of an anti-p185HER2 antibody for human cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900228-7

7 January 2021

Preparation of an insulin with improved pharmacokinetics relative to human insulin through consideration of structural homology with insulin-like growth factor I.

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900228-7

7 January 2021

Consensus interferon: a novel interferon for the treatment of hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900228-7

7 January 2021

Basal insulin glargine (HOE 901) versus NPH insulin in patients with type 1 diabetes on multiple daily insulin regimens. U.S. Insulin Glargine (HOE 901) Type 1 Diabetes Investigator Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900228-7

7 January 2021

Humanized antibodies as potential therapeutic drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900228-7

7 January 2021

Immunoscintigraphy performed with In-111-labeled CYT-103 in the management of colorectal cancer: comparison with CT.

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900228-7

7 January 2021

The development of hirudin as an antithrombotic drug

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900228-7

7 January 2021

Interferon-α2Variants in the Human Genome

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2800%2900228-7

7 January 2021

10.1016/S0958-1669(00)00228-7

Identifiers

DOI

1 reference

1 August 2017

1 reference